FDA Inspection
Lonza Bend Inc.Lonza Bend Inc. – FDA Inspection, May 19, 2026
Record Details
This FDA Inspection record concerns Lonza Bend Inc., with an inspection on May 19, 2026, issued by the Seattle District Office, covering human drugs.
View Company Profile
ID · 94b8327e-8fdd-4eb5-a82d-ce8a2c0eb9b8
Inspection Facts
- Inspection number
- 1317820
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Lonza Bend Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| May 24, 2023 | VAI | Seattle District Office | |
| August 5, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 27, 2018 | Not classified | Seattle District Office | |
| July 27, 2018 | Not classified | Seattle District Office | |
| July 21, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Lonza Bend Inc.
- FDA Inspection 1206164 - 2023-05-24
- FDA Inspection 1178398 - 2022-08-05
- FDA Inspection 1065493 - 2018-07-27
- FDA Inspection 1060190 - 2018-07-27
- FDA Inspection 1018924 - 2017-07-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.